318 related articles for article (PubMed ID: 24341078)
1. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
Jain D; Darrow JJ
Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
[TBL] [Abstract][Full Text] [Related]
2. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
Guennif S
Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
[TBL] [Abstract][Full Text] [Related]
4. Patents versus patients? Antiretroviral therapy in India.
Havlir DV; Hammer SM
N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
[No Abstract] [Full Text] [Related]
5. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
6. Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?
Beck EJ; Mandalia S; DongmoNguimfack B; Pinheiro E; 't Hoen E; Boulet P; Stover J; Gupta A; Juneja S; Habiyambere V; Ghys P; Nunez C
Glob Health Action; 2019; 12(1):1586317. PubMed ID: 30983547
[TBL] [Abstract][Full Text] [Related]
7. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
Halliburton M
Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
[TBL] [Abstract][Full Text] [Related]
9. The new patent regime and disease priorities in India.
Gupta I; Guin P; Trivedi M
Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021
[TBL] [Abstract][Full Text] [Related]
10. Global patent police block cost-reduction efforts.
Kasper T
GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
[TBL] [Abstract][Full Text] [Related]
11. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
12. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
13. The Brazilian experiment: HIV drugs for all.
Flaer PJ; Younis MZ
J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
[TBL] [Abstract][Full Text] [Related]
14. Compulsory licensing and access to drugs.
Stavropoulou C; Valletti T
Eur J Health Econ; 2015 Jan; 16(1):83-94. PubMed ID: 24408475
[TBL] [Abstract][Full Text] [Related]
15. Learning from practice: compulsory licensing cases and access to medicines.
Stirner B
Pharm Pat Anal; 2012 Nov; 1(5):555-75. PubMed ID: 24236925
[TBL] [Abstract][Full Text] [Related]
16. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.
't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV
Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417
[TBL] [Abstract][Full Text] [Related]
17. Learning from practice: compulsory licensing cases and access to medicines.
Stirner B; Thangaraj H
Pharm Pat Anal; 2013 Mar; 2(2):195-213. PubMed ID: 24237026
[TBL] [Abstract][Full Text] [Related]
18. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand.
Kuek V; Phillips K; Kohler JC
Glob Public Health; 2011; 6(2):111-24. PubMed ID: 20234967
[TBL] [Abstract][Full Text] [Related]
19. A method for understanding generic procurement of HIV medicines by developing countries with patent protection.
Beall RF; Attaran A
Soc Sci Med; 2017 Jul; 185():118-126. PubMed ID: 28578209
[TBL] [Abstract][Full Text] [Related]
20. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
Ford N; Wilson D; Costa Chaves G; Lotrowska M; Kijtiwatchakul K
AIDS; 2007 Jul; 21 Suppl 4():S21-9. PubMed ID: 17620749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
